Patents Assigned to Ionix Pharmaceuticals Limited
  • Analgesics
    Publication number: 20070231269
    Abstract: An analgesic and a delivery agent are combined in a pharmaceutical composition such that, on introduction into the nasal cavity of a patient to be treated, the analgesic may be delivered to the bloodstream to produce within 30 minutes a therapeutic plasma concentration, Cther, of 0.2 ng/ml or greater which is maintained for a duration Tmaint of at least 2 hours. The analgesic may be an opioid analgesic or a non-steroidal anti-inflammatory drug.
    Type: Application
    Filed: May 14, 2007
    Publication date: October 4, 2007
    Applicants: IONIX PHARMACEUTICALS LIMITED, ARCHIMEDES DEVELOPMENT LIMITED
    Inventors: Phillip Birch, Ann Hayes, Peter Watts, Jonathan Castile
  • Ion channel
    Patent number: 7112418
    Abstract: The present invention relates to a novel 1,957 amino acid tetrodotoxin-insensitive voltage-gated sodium channel specifically located in mammalian sensory neurons. Nucleic acid sequences coding for the novel sodium channel, vectors, host cells and methods of identifying modulators of the novel sodium channel for use in treatment of pain are also provided.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: September 26, 2006
    Assignee: Ionix Pharmaceuticals Limited
    Inventors: John Nicholas Wood, Armen Norakovitch Akopian
  • Ion channel
    Publication number: 20050221394
    Abstract: The present invention relates to a novel 1,957 amino acid tetrodotoxin-insensitive voltage-gated sodium channel specifically located in mammalian sensory neurons. Nucleic acid sequences coding for the novel sodium channel, vectors, host cells and methods of identifying modulators of the novel sodium channel for use in treatment of pain are also provided.
    Type: Application
    Filed: May 25, 2005
    Publication date: October 6, 2005
    Applicant: IONIX PHARMACEUTICALS LIMITED
    Inventors: John Wood, Armen Akopian
  • Ion channel
    Publication number: 20030176648
    Abstract: The present invention relates to a novel 1,957 amino acid tetrodotoxin-insensitive voltage-gated sodium channel specifically located in mammalian sensory neurons. Nucleic acid sequences coding for the novel sodium channel, vectors, host cells and methods of identifying modulators of the novel sodium channel for use in treatment of pain are also provided.
    Type: Application
    Filed: July 26, 2002
    Publication date: September 18, 2003
    Applicant: IONIX PHARMACEUTICALS LIMITED
    Inventors: John Nicholas Wood, Armen Norakovitch Akopian
  • Ion channel
    Patent number: 6451554
    Abstract: The present invention relates to a novel 1,957 amino acid tetrodotoxin-insensitive voltage-gated sodium channel specifically located in mammalian sensory neurons. Nucleic acid sequences coding for the novel sodium channel, vectors, host cells and methods of identifying modulators of the novel sodium channel for use in treatment of pain are also provided.
    Type: Grant
    Filed: June 24, 1996
    Date of Patent: September 17, 2002
    Assignee: Ionix Pharmaceuticals Limited
    Inventors: John Nicholas Wood, Armen Norakovitch Akopian